This evidence is in line with our findings, as we observed that the EGFR-mutant NSCLC cell line H1975 accumulated in G2–M, slowed down its in culture proliferation ability, and showed tumor growth inhibition in xenograft models, upon treatment with Unesbulin. This evidence concerns the gene EGFR and neoplasm.